SCHEMBL6277591

SCHEMBL6277591

NC(O)CS(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL28516928 0.79 CA5A (0.35)
SCHEMBL28794128 0.78 SLC22A6 (0.36)
SCHEMBL27458968 0.78 GCLC (0.30)
SCHEMBL28518010 0.78
SCHEMBL28600525 0.75
SCHEMBL28694427 0.73 SLC22A6 (0.46)
SCHEMBL270855 0.73
SCHEMBL9341820 0.73 SLC22A6 (0.46)
Ethylene SCHEMBL8854273 0.73 SLC22A6 (0.40)
SCHEMBL8527696 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040197293-A1 Anionic polyurethanes with elastic property L'OREAL S.A. (FR) 2004-10-07 US claimed
CN-120189413-A Application of atropine in treating fundus lesions 南方医科大学第三附属医院(广东省骨科研究院) 2025-06-24 CN disclosed
US-20240000755-A1 PHARMACEUTICAL COMPOSITION COMPRISING SULBACTAM AND AVIBACTAM, AND APPLICATION THEREOF TENNOR THERAPEUTICS (SUZHOU) LIMITED (CN) 2024-01-04 US disclosed
CN-102245677-B Silicone-containing polyurethane foam WACKER CHEMIE AG 2014-07-02 CN disclosed
CN-103282397-A Silicon-containing polyurethane foam WACKER CHEMIE AG 2013-09-04 CN disclosed
CN-102892804-A Polyurethane foam containing silicon WACKER CHEMIE AG 2013-01-23 CN disclosed
CN-102844347-A Silicon-containing polyisocyanurate foam WACKER CHEMIE AG 2012-12-26 CN disclosed
CN-102245677-A Silicone-containing polyurethane foam WACKER CHEMIE AG 2011-11-16 CN disclosed
EP-0923370-B1 ACETYL CHOLINE ESTERASE INHIBITORS FOR TREATING AND DIAGNOSING SLEEP DISORDERED BREATHING CURAPATH AB (SE) 2005-11-16 EP disclosed
US-20040197293-A1 Anionic polyurethanes with elastic property L'OREAL S.A. (FR) 2004-10-07 US disclosed
US-6034117-A Methods of treating and diagnosing sleep disordered breathing and means for carrying out the method PHARMAPNEA AB (SE) 2000-03-07 US disclosed
US-5962828-A Enhanced flotation reagents for beneficiation of phosphate ores CUSTOM CHEMICALS CORPORATION (US) 1999-10-05 US disclosed
EP-0923370-A2 METHOD OF TREATING AND DIAGNOSING SLEEP DISORDERED BREATHING AND MEANS FOR CARRYING OUT THE METHOD A+ Science Invest AB (SE) 1999-06-23 EP disclosed
CN-1036045-C Cold ironing agent using pseudo-glycolylthiourea acid as main agent and its preparing process GUANGZHOU INST OF CHEMISTRY (CN) 1997-10-08 CN disclosed
WO-1997022339-A1 METHOD OF TREATING AND DIAGNOSING SLEEP DISORDERED BREATHING AND MEANS FOR CARRYING OUT THE METHOD HEDNER JAN (SE) 1997-06-26 WO disclosed
US-5466696-A Mixtures for treatment of alzheimer's disease WARNER LAMBERT COMPANY (US) 1995-11-14 US disclosed
EP-0659082-A1 USE OF CYTOCHROME P450 INHIBITORS FOR INHIBITING THE METABOLISM OF NITROGEN SUBSTITUTED ACRIDINE WARNER-LAMBERT COMPANY (US) 1995-06-28 EP disclosed
US-5422350-A Alzheimer's disease WARNER-LAMBERT COMPANY (US) 1995-06-06 US disclosed
WO-1994005296-A2 USE OF CYTOCHROME P450 INHIBITORS FOR INHIBITING THE METABOLISM OF NITROGEN SUBSTITUTED ACRIDINE WARNER-LAMBERT COMPANY (US) 1994-03-17 WO disclosed
EP-0018708-B1 DECORATION TRANSFER MATERIAL, METHOD OF DECORATING A SUBSTRATE USING SUCH A TRANSFER MATERIAL, AND PRINTING INK THEREFOR Decor Innovations Limited (GB) 1981-10-07 EP disclosed